News | February 25, 2015

Seattle Cancer Care Alliance Proton Therapy Adds New Advanced Treatment Options

Pencil beam scanning, breath-hold device among new innovations

SCCA, proton therapy, radiation, RaySearch, RayStation, Active Breathing

February 25, 2015 — Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.

“PBS is the most advanced way to deliver proton radiation and will allow us to sculpt protons for treating more complex tumors, such as in the head and neck, lung, abdomen, and pelvic areas,” said Smith ‘Jim’ Apisarnthanarax, M.D., a radiation oncologist at SCCA Proton Therapy.

SCCA Proton Therapy has also recently become the first proton center to use an advanced breath-hold device that aids patients in their ability to control breathing during radiation treatment. The Active Breathing Coordinator (ABC) device may be used when treating tumors in the chest or abdomen that move with breathing. It assists patients with systematically holding their breath before or after they’ve breathed out.

During this brief time, the ABC device makes the tumor a stationary target, allowing the treatment to be even more accurate, sparing surrounding tissue. The device’s ability to control breath both on inhale and exhale allows physicians to treat a range of tumors.

In addition, University of Washington Medicine physicians and SCCA Proton Therapy physicists are working together to upgrade the process for developing PBS patient treatment plans with RaySearch Laboratories‘ advanced treatment-planning and dose-tracking software platform, RayStation. RayStation combines the capabilities of traditional imaging such as computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI), with contouring and 4-D compatibility. Other features include multi-criteria optimization, dose tracking, treatment adaptation and near-real-time deformable image registration.

“Providing patients with the best treatment possible is our No. 1 priority and we believe investing in these advancements allows us to provide them with the highest levels of care,” said Ramesh Rengan, M.D., medical director at SCCA Proton Therapy. “These innovative technologies will make treatments more effective for patients, while shortening the overall treatment course for select cancers.”

For more information: www.sccaprotontherapy.com

Related Content

Videos | Treatment Planning | August 21, 2019
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and
First Cancer Patient Treated With Accuray Radixact System With Synchrony Motion Tracking
News | Image Guided Radiation Therapy (IGRT) | August 21, 2019
Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have...
Videos | Patient Positioning Radiation Therapy | August 21, 2019
This is a quick demonstration of the Varian Identify image-guided patient positioning system at the...
Videos | Treatment Planning | August 21, 2019
This is a lung cancer tumor radiotherapy...
Videos | Computed Tomography (CT) | August 21, 2019
This is a quick walk around of a mobile 32-slice...
First GammaTile Therapy Case Completed in Arizona
News | Radiation Therapy | August 19, 2019
HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a...
Drug Accelerates Blood System's Recovery After Radiation, Chemotherapy

Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications

News | Radiation Therapy | August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem...
Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality

Catalyst PT image courtesy of C-RAD

News | Patient Positioning Radiation Therapy | August 15, 2019
Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton...